Why do we need to diversify our digitization strategy, looking beyond legacy models that prevent complete, end-to-end digital manufacturing?
How can a light, configurable MES remove paper from production entirely and enable any-sized pharma company to fully utilize their MES across all lines and sites?
How can a modern MES digitally connect different data sources to close offline data gaps, improve data integrity and visibility, and unlock critical business intelligence?